Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 215455 (Aug 8, 2024)

Issued August 8, 2024

Issued

August 8, 2024

Application

NDA 505b1 • 215455

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due November 6, 2024Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…